Structural basis for distinct functions of the naturally occurring cys mutants of human apolipoprotein A-I

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3244-3257

  Gursky, Olga ^a   Jones, Martin K ^b   Mei, Xiaohu ^a   Segrest, Jere P ^b   Atkinson, David ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Atherosclerosis; Double belt and trefoil tetrafoil conformations; Milano and Paris mutations; Protein dynamics and function; Protein lipid interactions

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CYSTEINE; DISULFIDE; GLYCINE; HIGH DENSITY LIPOPROTEIN; MUTANT PROTEIN; PROLINE;

ATHEROSCLEROSIS; CARBOXY TERMINAL SEQUENCE; HEART PROTECTION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ATHEROSCLEROSIS; DOUBLE-BELT AND TREFOIL/TETRAFOIL CONFORMATIONS; MILANO AND PARIS MUTATIONS; PROTEIN DYNAMICS AND FUNCTION; PROTEIN-LIPID INTERACTIONS;

APOLIPOPROTEIN A-I; CYSTEINE; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY;

EID: 84887888863     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R037911     Document Type: Review

References (74)

1. Rothblat, G. H., and M. C. Phillips. 2010. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr. Opin. Lipidol. 21:229-238.
2. Voight, B. F., G. M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, M. K. Jensen, G. Hindy, H. Hólm, E. L. Ding, T. Johnson, et al. 2012. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 380:572-580.
3. Borhani, D. W., D. P. Rogers, J. A. Engler, and C. G. Brouillette. 1997. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:12291-12296. (Pubitemid 27492521)
4. Segrest, J. P., M. K. Jones, A. E. Klon, C. J. Sheldahl, M. Hellinger, H. De Loof, and S. C. Harvey. 1999. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J. Biol. Chem. 274:31755-31758.
5. Brouillette, C. G., G. M. Anantharamaiah, J. A. Engler, and D. W. Borhani. 2001. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim. Biophys. Acta. 1531:4-46. (Pubitemid 32241248)
6. Sorci-Thomas, M. G., J. S. Owen, B. Fulp, S. Bhat, X. Zhu, J. S. Parks, D. Shah, W. G. Jerome, M. Gerelus, M. Zabalawi, et al. 2012. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers. J. Lipid Res. 53:1890-1909.
7. Silva, R. A., R. Huang, J. Morris, J. Fang, E. O. Gracheva, G. Ren, A. Kontush, W. G. Jerome, K. A. Rye, and W. S. Davidson. 2008. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc. Natl. Acad. Sci. USA. 105:12176-12181.
8. Huang, R., R. A. Silva, W. G. Jerome, A. Kontush, M. J. Chapman, L. K. Curtiss, T. J. Hodges, and W. S. Davidson. 2011. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 18:416-422.
9. Gursky, O. 2013. Crystal structure of Δ (185-243) apoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil/tetrafoil. J. Mol. Biol. 425:1-16.
10. Bhat, S., M. G. Sorci-Thomas, L. Calabresi, M. P. Samuel, and M. J. Thomas. 2010. Conformation of dimeric apolipoprotein A-I Milano on recombinant lipoprotein particles. Biochemistry. 49:5213-5224.
11. Lund-Katz, S., and M. C. Phillips. 2010. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 51:183-227.
12. Segrest, J. P., D. W. Garber, C. G. Brouillette, S. C. Harvey, and G. M. Anantharamaiah. 1994. The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45:303-369. (Pubitemid 24139891)
13. Rosenson, R. S., H. B. Brewer, Jr., W. S. Davidson, Z. A. Fayad, V. Fuster, J. Goldstein, M. Hellerstein, X. C. Jiang, M. C. Phillips, D. J. Rader, et al. 2012. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 125:1905-1919.
14. Oram, J. F., and J. W. Heinecke. 2005. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85:1343-1372. (Pubitemid 41362273)
15. Yvan-Charvet, L., N. Wang, and A. R. Tall. 2010. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 30:139-143.
16. Gordon, S. M., S. Hofmann, D. S. Askew, and W. S. Davidson. 2011. High density lipoprotein: it's not just about lipid transport anymore. Trends Endocrinol. Metab. 22:9-15.
17. Gao, X., and S. Yuan. 2010. High density lipoproteins-based therapies for cardiovascular disease. J. Cardiovasc. Dis. Res. 1:99-103.
18. Tardif, J. C. 2010. Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology? J. Clin. Lipidol. 4:399-404.
19. Franceschini, G., C. R. Sirtori, A. Capurso 2nd, K. H. Weisgraber, and R. W. Mahley. 1980. A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J. Clin. Invest. 66:892-900. (Pubitemid 11233787)
20. Sirtori, C. R., L. Calabresi, G. Franceschini, D. Baldassarre, M. Amato, J. Johansson, M. Salvetti, C. Monteduro, R. Zulli, M. L. Muiesan, et al. 2001. Cardiovascular status of carriers of the apolipoprotein A-I Milano mutant: the Limone sul Garda study. Circulation. 103:1949-1954. (Pubitemid 32322221)
21. Bruckert, E., A. Von Eckardstein, H. Funke, I. Beucler, H. Wiebusch, G. Turpin, and G. Assmann. 1997. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-I Milano. Atherosclerosis. 128:121-128. (Pubitemid 27065268)
22. Bielicki, J. K., and M. N. Oda. 2002. Apolipoprotein A-I (Milano) and apolipoprotein A-I (Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry. 41:2089-2096. (Pubitemid 34132283)
23. Cimmino, G., B. Ibanez, G. Vilahur, W. S. Speidl, V. Fuster, L. Badimon, and J. J. Badimon. 2009. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I (Milano). J. Cell. Mol. Med. 13(9B):3226-3235.
24. Calabresi, L., C. R. Sirtori, R. Paoletti, and G. Franceschini. 2006. Recombinant apolipoprotein A-I Milano for the treatment of cardiovascular diseases. Curr. Atheroscler. Rep. 8:163-167.
25. Kaul, S., and P. K. Shah. 2005. ApoA-I Milano/phospholipid complexes emerging pharmacological strategies and medications for the prevention of atherosclerotic plaque progression. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5:471-479. (Pubitemid 43008520)
26. Nissen, S. E., T. Tsunoda, E. M. Tuzcu, P. Schoenhagen, C. J. Cooper, M. Yasin, G. M. Eaton, M. A. Lauer, W. S. Sheldon, C. L. Grines, et al. 2003. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 290:2292-2300. (Pubitemid 37430562)
27. Kaul, S., B. Coin, A. Hedayiti, J. Yano, B. Cercek, K. Y. Chyu, and P. K. Shah. 2004. Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-I (Milano)-phospholipid complex. J. Am. Coll. Cardiol. 44:1311-1319. (Pubitemid 39208891)
28. Chiesa, G., C. Parolini, and C. R. Sirtori. 2008. Acute effects of highdensity lipoproteins: biochemical basis and clinical findings. Curr. Opin. Cardiol. 23:379-385. (Pubitemid 351787104)
29. Speidl, W. S., G. Cimmino, B. Ibanez, S. Elmariah, R. Hutter, M. J. Garcia, V. Fuster, M. E. Goldman, and J. J. Badimon. 2010. Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. Eur. Heart J. 31:2049-2057.
30. Ibanez, B., C. Giannarelli, G. Cimmino, C. G. Santos-Gallego, M. Alique, A. Pinero, G. Vilahur, V. Fuster, L. Badimon, and J. J. Badimon. 2012. Recombinant HDL (Milano) exerts greater antiinflammatory and plaque stabilizing properties than HDL (wildtype). Atherosclerosis. 220:72-77.
31. Parolini, C., G. Chiesa, E. Gong, S. Caligari, M. M. Cortese, T. Koga, T. M. Forte, and E. M. Rubin. 2005. Apolipoprotein A-I and the molecular variant apoA-I (Milano): evaluation of the antiatherogenic effects in knock-in mouse model. Atherosclerosis. 183:222-229. (Pubitemid 41579271)
32. Calabresi, L., M. Canavesi, F. Bernini, and G. Franceschini. 1999. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-I Milano dimer. Biochemistry. 38:16307-16314. (Pubitemid 129520553)
33. Wang, W. Q., A. S. Moses, and G. A. Francis. 2001. Cholesterol mobilization by free and lipid-bound apoAI (Milano) and apoAI (Milano) - apoAII heterodimers. Biochemistry. 40:3666-3673. (Pubitemid 32242824)
34. Weibel, G. L., E. T. Alexander, M. R. Joshi, D. J. Rader, S. Lund-Katz, M. C. Phillips, and G. H. Rothblat. 2007. Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux. Arterioscler. Thromb. Vasc. Biol. 27:2022-2029. (Pubitemid 47312313)
35. Alexander, E. T., G. L. Weibel, M. R. Joshi, C. Vedhachalam, M. De La Llera-Moya, G. H. Rothblat, M. C. Phillips, and D. J. Rader. 2009. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano. Arterioscler. Thromb. Vasc. Biol. 29:1496-1501.
36. Zhu, X., G. Wu, W. Zeng, H. Xue, and B. Chen. 2005. Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties. J. Lipid Res. 46:1303-1311. (Pubitemid 43109845)
37. Li, L., S. Li, M. K. Jones, and J. P. Segrest. 2012. Rotational and hinge dynamics of discoidal high density lipoproteins probed by interchain disulfide bond formation. Biochim. Biophys. Acta. 1821:481-489.
38. Klon, A. E., M. K. Jones, J. P. Segrest, and S. C. Harvey. 2000. Molecular belt models for the apolipoprotein A-I Paris and Milano mutations. Biophys. J. 79:1679-1685.
39. Franceschini, G., T. G. Frosi, C. Manzoni, G. Gianfranceschi, and C. R. Sirtori. 1982. High density lipoprotein-3 heterogeneity in subjects with the apo-AI Milano variant. J. Biol. Chem. 257:9926-9930.
40. Favari, E., M. Gomaraschi, I. Zanotti, F. Bernini, M. Lee-Rueckert, P. T. Kovanen, C. R. Sirtori, G. Franceschini, and L. Calabresi. 2007. A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I (Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux. J. Biol. Chem. 282:5125-5132. (Pubitemid 47093758)
41. Weisgraber, K. H., S. C. Rall, Jr., T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori. 1983. Apolipoprotein A-I Milano detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J. Biol. Chem. 258:2508-2513. (Pubitemid 13118451)
42. Daum, U., C. Langer, N. Duverger, F. Emmanuel, P. Benoit, P. Denèfle, A. Chirazi, P. Cullen, P. H. Pritchard, E. Bruckert, et al. 1999. Apolipoprotein A-I (R151C) Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux. J. Mol. Med. 77:614-622. (Pubitemid 29479982)
43. Perez-Mendez, O., E. Bruckert, G. Franceschini, N. Duhal, B. Lacroix, J. P. Bonte, C. Sirtori, J. C. Fruchart, G. Turpin, and G. Luc. 2000. Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris. Atherosclerosis. 148:317-325. (Pubitemid 30064463)
44. Roma, P., R. E. Gregg, M. S. Meng, R. Ronan, L. A. Zech, G. Franceschini, C. R. Sirtori, and H. B. Brewer, Jr. 1993. In vivo metabolism of a mutant form of apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. J. Clin. Invest. 91:1445-1452. (Pubitemid 23127345)
45. Calabresi, L., G. Franceschini, A. Burkybile, and A. Jonas. 1997. Activation of lecithin cholesterol acyltransferase by a disulfidelinked apolipoprotein A-I dimer. Biochem. Biophys. Res. Commun. 232:345-349. (Pubitemid 27216216)
46. Sparks, D. L., W. S. Davidson, S. Lund-Katz, and M. C. Phillips. 1995. Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J. Biol. Chem. 270:26910-26917.
47. Milano dimer. The introduction of an interchain disulfide bridge remarkably alters the physicochemical properties of apolipoprotein A-I. J. Biol. Chem. 269:32168-32174.
48. Chetty, P. S., M. Ohshiro, H. Saito, P. Dhanasekaran, S. Lund-Katz, L. Mayne, W. Englander, and M. C. Phillips. 2012. Effects of the Iowa and Milano mutations on apolipoprotein A-I structure and dynamics determined by hydrogen exchange and mass spectrometry. Biochemistry. 51:8993-9001.
49. Gianazza, E., I. Eberini, C. R. Sirtori, G. Franceschini, and L. Calabresi. 2002. Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins. Biochem. J. 366:245-253. (Pubitemid 34971824)
50. Alexander, E. T., M. Tanaka, M. Kono, H. Saito, D. J. Rader, and M. C. Phillips. 2009. Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I. J. Lipid Res. 50:1409-1419.
51. Calabresi, L., G. Tedeschi, C. Treu, S. Ronchi, D. Galbiati, S. Airoldi, C. R. Sirtori, Y. Marcel, and G. Franceschini. 2001. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. J. Lipid Res. 42:935-942. (Pubitemid 32545849)
52. Saito, H., P. Dhanasekaran, D. Nguyen, P. Holvoet, S. Lund-Katz, and M. C. Phillips. 2003. Domain structure and lipid interaction in human apolipoproteins A-I and E, a general model. J. Biol. Chem. 278:23227-23232. (Pubitemid 36830135)
53. Mei, X., and D. Atkinson. 2011. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J. Biol. Chem. 286:38570-38582.
54. Segrest, J. P., M. K. Jones, A. Catte, and S. P. Thirumuruganandham. 2012. Validation of previous computer models and MD simulations of discoidal HDL by a recent crystal structure of apoA-I. J. Lipid Res. 53:1851-1863.
55. Jayaraman, S., G. Cavigiolio, and O. Gursky. 2012. Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: Relevance to HDL biogenesis. Biochem. J. 442:703-712.
56. Gursky, O., X. Mei, and D. Atkinson. 2012. Crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on the amyloid formation by the N-terminal segment. Biochemistry. 51:10-18.
57. Gao, X., S. Yuan, S. Jayaraman, and O. Gursky. 2012. Effect of apolipoprotein A-II on the structure and stability of human high-density lipoprotein: Implications for the role of apoA-II in HDL metabolism. Biochemistry. 51:4633-4641.
58. Milano-apoA-II supports its peculiar susceptibility to proteolysis. Biophys. J. 91:3043-3049. (Pubitemid 44526494)
59. Rocco, A. G., C. Sensi, E. Gianazza, L. Calabresi, G. Franceschini, C. R. Sirtori, and I. Eberini. 2010. Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL. J. Mol. Graph. Model. 29:406-414.
60. Calabresi, L., G. Vecchio, F. Frigerio, L. Vavassori, C. R. Sirtori, and G. Franceschini. 1997. Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity. Biochemistry. 36:12428-12433. (Pubitemid 27446665)
61. Kalé, L., R. Skeel, M. Bhandarkar, R. Brunner, A. Gursoy, N. Krawetz, J. Phillips, A. Shinozaki, K. Varadarajan, and K. Schulten. 1999. NAMD2: greater scalability for parallel molecular dynamics. J. Comput. Phys. 151:283-312.
62. Jones, M. K., A. Catte, J. C. Patterson, F. Gu, J. Chen, L. Li, and J. P. Segrest. 2009. Thermal stability of apolipoprotein A-I in high-density lipoproteins by molecular dynamics. Biophys. J. 96:354-371.
63. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:33-38. (Pubitemid 26152973)
64. Jorgensen, W. L., J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
65. Brooks, B. R., R. E. Bruccoleri, B. D. Olafson, D. J. States, S. Swaminathan, and M. Karplus. 1983. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4:187-217.
66. MacKerell, A. D., Jr., D. Bashford, R. L. Dunbrack, Jr., J. D. Evanseck, M. J. Field, S. Fischer, J. Gao, H. Guo, S. Ha, D. Joseph-McCarthy, et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102:3586-3616. (Pubitemid 128576688)
67. Feller, S. E., and R. W. Pastor. 1997. Length scales of lipid dynamics and molecular dynamics. Pac. Symp. Biocomput. 1997:142-150.
68. Schlenkrich, M., J. Brickmann, A. MacKerell, Jr., and M. Karplus. 1996. An empirical potential energy function for phospholipids: criteria for parameter optimization and applications. In Biological Membranes: A Molecular Perspective from Computation and Experiment. K. M. Merz and B. Roux, editoirs. Birkhauser, Boston. 31-81.
69. Bashtovyy, D., M. K. Jones, G. M. Anantharamaiah, and J. P. Segrest. 2011. Analyses of sequence conservation of apolipoprotein A-I afford novel insights into HDL structure-function. J. Lipid Res. 52:435-450.
70. Vaisar, T. 2012. Proteomics investigations of HDL: challenges and promise. Curr. Vasc. Pharmacol. 10:410-421.
71. Nagata, K. O., C. Nakada, R. S. Kasai, A. Kusumi, and K. Ueda. 2013. ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging. Proc. Natl. Acad. Sci. USA. 110:5034-5039.
72. Mei, X., and D. Atkinson. 2013. Probing the structure and function of apoA-I C-terminal domain during HDL formation. (Abstract 2021 in ASBMB Annual Meeting. Boston MA, April 20-24, 2013.).
73. Maiorano, J. N., R. J. Jandacek, E. M. Horace, and W. S. Davidson. 2004. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size. Biochemistry. 43:11717-11726. (Pubitemid 39277617)
74. Martin, D. D., M. S. Budamagunta, R. O. Ryan, J. C. Voss, and M. N. Oda. 2006. Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein. J. Biol. Chem. 281:20418-20426. (Pubitemid 44065815)